Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in own shares executed under the Company's share buyback programme announced on March 28, 2025.
Key Financial Metrics and Transaction Details
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity:
- Date of Purchase: June 11, 2025
- Shares Purchased: 974,260 ordinary shares
- Price Range: Lowest 396.30p; Highest 400.10p
- Volume Weighted Average Price: 399.00p
- Post-Transaction Capital: 8,998,501,127 ordinary shares registered; 4,080,205 held as treasury shares.
- Voting Rights: 8,994,420,922 ordinary shares with voting rights.
Material Changes
The primary material change is the reduction of the Company's share count due to the cancellation of 974,260 shares purchased on June 11, 2025. This action reduces the number of shares held as treasury stock and adjusts the total number of shares with voting rights.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation for securities. A full breakdown of individual trades is referenced as available via the London Stock Exchange and the Company's website.
Key Facts for Investor Verification
- Verify the total number of shares purchased under the buyback programme since its inception on March 28, 2025.
- Confirm the remaining authorization limit for the current buyback programme.
- Review the full trade breakdown at the provided RNS link for intraday pricing details.
- Check the Company's website for updated treasury share holdings and voting rights calculations.